One-stop PROLASTIN-C enrollment, delivery and support

Prolastin Direct® Patient Services secures insurance authorization, coordinates infusion services, ships PROLASTIN-C directly to the location of your choice, and connects you to health management coordinators who are experienced Alpha-1 patients themselves. Find out more about Prolastin Direct® Patient Services now.

Where To Get PROLASTIN-C Infusions

You can receive an infusion of PROLASTIN-C:

  • In a doctor's office
  • In a hospital clinic
  • In a facility where IV infusions are routinely given
  • In your home
  • In the location of your choice even when you travel

Many companies offer infusion services for medicines like PROLASTIN-C, so you can receive them in the comfort of your own home. The staff at Prolastin Direct® will assist in determining the best locations for your infusions.

You or a family member can infuse PROLASTIN-C

If you are motivated to do it, and you are physically able, you can learn to administer PROLASTIN-C to yourself. A willing family member or significant other can also be trained to give you infusions of PROLASTIN-C.

Nurses may be available to train you or your caregiver on all aspects of home administration. For patients who choose to learn home self-infusion techniques, safety is always a primary goal.

Find a Clinical Resource Center near you

There are over 50 Clinical Resource Centers in North America that specialize in patient care and education for patients with Alpha-1. Find the nearest Clinical Resource Centers by visiting the Alpha-1 Foundation Web site.

next: Augmentation Therapy >

Important Safety Information
Prolastin-C, Alpha1-Proteinase Inhibitor (Human) is for adults who have emphysema caused by inherited alpha1-antitrypsin deficiency. The effect of therapy with any alpha1-proteinase inhibitor (alpha1-PI) on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Prolastin-C may contain trace amounts of IgA. IgA deficient patients with antibodies against IgA should not receive Prolastin-C due to the risk of hypersensitivity.

The most common side effects during clinical trials with Prolastin-C were chills, a general feeling of being unwell, headache, rash, hot flush, and itching.

Prolastin-C is made from human plasma. Products made from human plasma may carry a risk of transmitting infectious agents, e.g., viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

Please see accompanying Prolastin-C Full Prescribing Information for complete prescribing details.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.